Intervention: Drug: KL-A167 Injection
Sponsor: Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.
Not yet recruiting
https://ift.tt/2GDytCi
Τετάρτη 20 Φεβρουαρίου 2019
KL-A167 Injection in Recurrent or Metastatic Nasopharyngeal Carcinoma Who Have Received Previous At Least Two Lines of Chemotherapy
Intervention: Drug: KL-A167 Injection
Sponsor: Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.
Not yet recruiting
https://ift.tt/2GDytCi
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Summary Insulinomas are rare neuroendocrine tumours that classically present with fasting hypoglycaemia. This case report discusses an un...
-
The online platform for Taylor & Francis Online content New for Canadian Journal of Remote Sen...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου